These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

263 related articles for article (PubMed ID: 12138191)

  • 21. Regulation of cell cycle progression and apoptosis by the papillomavirus E6 oncogene.
    Fan X; Chen JJ
    Crit Rev Eukaryot Gene Expr; 2004; 14(3):183-202. PubMed ID: 15248815
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Comparison of human papillomavirus type 18 (HPV-18) E6-mediated degradation of p53 in vitro and in vivo reveals significant differences based on p53 structure and cell type but little difference with respect to mutants of HPV-18 E6.
    Gardiol D; Banks L
    J Gen Virol; 1998 Aug; 79 ( Pt 8)():1963-70. PubMed ID: 9714244
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Human papillomavirus oncogenic E6 protein regulates human β-defensin 3 (hBD3) expression via the tumor suppressor protein p53.
    DasGupta T; Nweze EI; Yue H; Wang L; Jin J; Ghosh SK; Kawsar HI; Zender C; Androphy EJ; Weinberg A; McCormick TS; Jin G
    Oncotarget; 2016 May; 7(19):27430-44. PubMed ID: 27034006
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Interaction of the human papillomavirus type 16 E6 oncoprotein with wild-type and mutant human p53 proteins.
    Scheffner M; Takahashi T; Huibregtse JM; Minna JD; Howley PM
    J Virol; 1992 Aug; 66(8):5100-5. PubMed ID: 1321290
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Mutant p53 can substitute for human papillomavirus type 16 E6 in immortalization of human keratinocytes but does not have E6-associated trans-activation or transforming activity.
    Sedman SA; Hubbert NL; Vass WC; Lowy DR; Schiller JT
    J Virol; 1992 Jul; 66(7):4201-8. PubMed ID: 1318401
    [TBL] [Abstract][Full Text] [Related]  

  • 26. The HPV E6 oncoprotein targets histone methyltransferases for modulating specific gene transcription.
    Hsu CH; Peng KL; Jhang HC; Lin CH; Wu SY; Chiang CM; Lee SC; Yu WC; Juan LJ
    Oncogene; 2012 May; 31(18):2335-49. PubMed ID: 21963854
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Intracellular Analysis of the Interaction between the Human Papillomavirus Type 16 E6 Oncoprotein and Inhibitory Peptides.
    Stutz C; Reinz E; Honegger A; Bulkescher J; Schweizer J; Zanier K; Travé G; Lohrey C; Hoppe-Seyler K; Hoppe-Seyler F
    PLoS One; 2015; 10(7):e0132339. PubMed ID: 26151636
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Targeted degradation of the retinoblastoma protein by human papillomavirus E7-E6 fusion proteins.
    Scheffner M; Münger K; Huibregtse JM; Howley PM
    EMBO J; 1992 Jul; 11(7):2425-31. PubMed ID: 1321031
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Papillomavirus type 16 oncogenes downregulate expression of interferon-responsive genes and upregulate proliferation-associated and NF-kappaB-responsive genes in cervical keratinocytes.
    Nees M; Geoghegan JM; Hyman T; Frank S; Miller L; Woodworth CD
    J Virol; 2001 May; 75(9):4283-96. PubMed ID: 11287578
    [TBL] [Abstract][Full Text] [Related]  

  • 30. High-risk HPV16E6 stimulates hADA3 degradation by enhancing its SUMOylation.
    Chand V; John R; Jaiswal N; Johar SS; Nag A
    Carcinogenesis; 2014 Aug; 35(8):1830-9. PubMed ID: 24795430
    [TBL] [Abstract][Full Text] [Related]  

  • 31. A comparative analysis of the interactions of the E6 proteins from cutaneous and genital papillomaviruses with p53 and E6AP in correlation to their transforming potential.
    Elbel M; Carl S; Spaderna S; Iftner T
    Virology; 1997 Dec; 239(1):132-49. PubMed ID: 9426453
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Alternatively spliced HPV-18 E6* protein inhibits E6 mediated degradation of p53 and suppresses transformed cell growth.
    Pim D; Massimi P; Banks L
    Oncogene; 1997 Jul; 15(3):257-64. PubMed ID: 9233760
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Human papillomavirus E6 and E7 oncoproteins alter cell cycle progression but not radiosensitivity of carcinoma cells treated with low-dose-rate radiation.
    DeWeese TL; Walsh JC; Dillehay LE; Kessis TD; Hedrick L; Cho KR; Nelson WG
    Int J Radiat Oncol Biol Phys; 1997 Jan; 37(1):145-54. PubMed ID: 9054890
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Multiple functions of human papillomavirus type 16 E6 contribute to the immortalization of mammary epithelial cells.
    Liu Y; Chen JJ; Gao Q; Dalal S; Hong Y; Mansur CP; Band V; Androphy EJ
    J Virol; 1999 Sep; 73(9):7297-307. PubMed ID: 10438818
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Inhibition of p53 DNA binding by human papillomavirus E6 proteins.
    Lechner MS; Laimins LA
    J Virol; 1994 Jul; 68(7):4262-73. PubMed ID: 8207801
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Targeting the Two Oncogenic Functional Sites of the HPV E6 Oncoprotein with a High-Affinity Bivalent Ligand.
    Ramirez J; Poirson J; Foltz C; Chebaro Y; Schrapp M; Meyer A; Bonetta A; Forster A; Jacob Y; Masson M; Deryckère F; Travé G
    Angew Chem Int Ed Engl; 2015 Jun; 54(27):7958-62. PubMed ID: 26014966
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Tale of a multifaceted co-activator, hADA3: from embryogenesis to cancer and beyond.
    Chand V; Nandi D; Mangla AG; Sharma P; Nag A
    Open Biol; 2016 Sep; 6(9):. PubMed ID: 27605378
    [TBL] [Abstract][Full Text] [Related]  

  • 38. The Human Papillomavirus E6 PDZ Binding Motif Links DNA Damage Response Signaling to E6 Inhibition of p53 Transcriptional Activity.
    Thatte J; Massimi P; Thomas M; Boon SS; Banks L
    J Virol; 2018 Aug; 92(16):. PubMed ID: 29848585
    [TBL] [Abstract][Full Text] [Related]  

  • 39. E6 oncoprotein represses p53-dependent gene activation via inhibition of protein acetylation independently of inducing p53 degradation.
    Thomas MC; Chiang CM
    Mol Cell; 2005 Jan; 17(2):251-64. PubMed ID: 15664194
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Cellular distribution of tumour suppressor protein p53 and high-risk human papillomavirus (HPV)-18 E6 fusion protein in wild-type p53 cell lines.
    Sun L; Zhang G; Li Z; Lei T; Huang C; Song T; Si L
    J Int Med Res; 2008; 36(5):1015-21. PubMed ID: 18831896
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 14.